Exscientia Plc American Depositary Shares
EXAI
EXAI was delisted on the 19th of November, 2024.
1 hedge funds and large institutions have $438K invested in Exscientia Plc American Depositary Shares in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 91 closing their positions.
99% less funds holding
Funds holding: 94 → 1 (-93)
100% less capital invested
Capital invested by funds: $129M → $438K (-$128M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 91
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SoftBank Group
Tokyo,
Japan
|
-$27.7M |
| 2 |
LCM
Laurion Capital Management
New York
|
-$21.8M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$18.8M |
| 4 |
MCMU
MIC Capital Management (UK)
London,
United Kingdom
|
-$7.53M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$7.11M |
EXAI Hedge Fund Activity: Q4 2024 in Review
1 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Exscientia Plc American Depositary Shares (EXAI) for Q4 2024, worth a combined $438K — down 100% from $129M a quarter earlier.
Sellers outnumbered buyers: 91 funds closed out of EXAI and 0 opened new positions — a net loss of 91 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was SoftBank Group, exiting entirely with an estimated $27.7M sold.
- 1 institutional investor held Exscientia Plc American Depositary Shares (EXAI) as of Q4 2024, down from 94 in Q3 2024.
- Funds reported $438K of Exscientia Plc American Depositary Shares stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new Exscientia Plc American Depositary Shares positions in Q4 2024 and 91 closed out, a net change of -91 holders.
- The largest Exscientia Plc American Depositary Shares seller in Q4 2024 was SoftBank Group, an estimated $27.7M sold.
Based on aggregated 13F filings for Q4 2024.